Skip to main content
Institutional deep-dive - valuation, health, statements

Financial Analysis

Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data

Fundamentals

U S PHYSICAL THERAPY INC /NV USPH

· Healthcare · Services-Health Services

FY2025 10-K, filed 2026-02-27
SEC EDGAR

Filing evidence summary

Mixed evidenceCoverage 5/5 core metrics

Flagged areas: Dilution.

Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.

Evidence signals

  • 1 filing risk check flagged

    Flagged areas: Dilution.

    Why this surfaced

    The full financial analysis shows each value, threshold, and sector limitation.

  • Revenue expanded

    Latest reported annual revenue changed +16.3% from the prior reported annual observation.

    Why this surfaced

    Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.

  • Operating margin improved

    Operating margin changed +1.7 percentage points from the prior annual period.

    Why this surfaced

    Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.

  • Free cash flow was positive

    Latest reported free cash flow was $61M.

    Why this surfaced

    Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.

Core trend metrics

Latest annual revenue growth
+16.3%
as of 2025-12-31
Latest annual operating margin
11.1%
as of 2025-12-31
Free cash flow
$61M
as of 2025-12-31
Debt / equity
0.32x
as of 2025-12-31
ROIC snapshot
10.3%
period varies

Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.

Where to look next

Risk checks

1of 10 rule-based checks flagged
  • Dilution

Financial movement

  • Cash→ flat
  • Long-term debt→ flat
  • Inventory→ flat
  • Receivables→ flat
  • Current assets→ flat

Source & freshness

Source
SEC EDGAR XBRL
Fetched
2026-09-06
Latest period end
2025-12-31
Filings
EDGAR ↗

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing
Fiscal year ending 2025-12-3110-K filed 2026-02-27prior period 2024-12-31 from the same filingView filing
By product or service
Revenue
  • Net Patient Revenues$650M
    82.3%
    +16.0% yoy
  • Other Revenues Including Management Contract Revenues And Industrial Injury Prevention Services Revenues$131M
    16.5%
    +17.8% yoy
  • Management Contract Revenues$9.6M
    1.2%
    -2.0% yoy

Members sum to the consolidated $781M for this period.

Latest quarter
Quarter ending 2026-03-3110-Q filed 2026-05-08prior period 2025-03-31 from the same filingView filing
  • Net Patient Revenues$164M
    82.1%
    +7.7% yoy
  • Other Revenues Including Management Contract Revenues And Industrial Injury Prevention Services Revenues$34M
    17.0%
    +8.7% yoy
  • Management Contract Revenues$1.8M
    0.9%
    -28.0% yoy

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

Peer percentiles

latest fiscal year ending 2025-12-31 · among 4,122 US-listed filers · 318 in Healthcare
MetricValuevs all filersvs sector
Revenue
latest fiscal-year revenue as filed
$781M
51stof 3,301
middle third
61stof 291
middle third
Revenue growth
latest fiscal-year revenue vs the prior fiscal year
16.3%
73rdof 3,135
top third
68thof 277
top third
Gross margin
gross profit ÷ revenue
19.2%
20thof 1,603
bottom third
6thof 212
bottom third
Operating margin
operating income ÷ revenue
11.1%
70thof 2,819
top third
76thof 280
top third
Net margin
net income ÷ revenue
5.1%
58thof 3,263
middle third
69thof 290
top third
Free-cash-flow margin
(operating cash flow − |capex|) ÷ revenue
7.8%
60thof 2,679
middle third
67thof 261
middle third
Return on equity
net income ÷ stockholders' equity (positive equity only)
8.3%
60thof 3,577
middle third
71stof 291
top third
Stock comp ÷ revenue
stock-based compensation ÷ revenue · lower is ranked higher
1.1%
66thof 2,895
middle third
78thof 272
top third
Days sales outstanding
receivables ÷ revenue × 365 · lower is ranked higher
30 days
73rdof 2,398
top third
88thof 266
top third
Net debt ÷ operating cash flow
net debt ÷ operating cash flow (OCF > 0) · lower is ranked higher
1.6×
56thof 1,547
middle third
56thof 116
middle third
Cash conversion
operating cash flow ÷ net income (net income > 0)
1.9×
64thof 2,183
middle third
61stof 123
middle third
Cash-flow accrual ratio
(net income − operating cash flow) ÷ average total assets · lower is ranked higher
-3.0%
39thof 3,577
middle third
25thof 272
bottom third
Balance-sheet accrual ratio
change in net operating assets ÷ average net operating assets · lower is ranked higher
3.1%
53rdof 3,059
middle third
50thof 237
middle third

Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.

Earnings quality

latest fiscal year ending 2025-12-31 · accruals and cash conversion as filed
Cash conversion
1.90×
operating cash flow ÷ net income, latest fiscal year
Cash-flow accrual ratio
-3.0%
(net income − operating cash flow) ÷ average total assets
Balance-sheet accrual ratio
3.1%
change in net operating assets ÷ average net operating assets
Cash-backed years
4 of 4
fiscal years where operating cash flow met or exceeded net income
Mean cash conversion
2.25×
across the stored fiscal years with positive net income

Per fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.

Point-in-time ledger

first-reported vs latest filing · periods since 2020-01-01 · 8 changed periods
Line itemPeriodFirst reportedLatest filingChangeFilings
Total assets
Assets
balance at 2021-03-31$598M
10-Q 2021-05-10
$749M
10-Q 2022-05-09
+25.2%first · latest
Operating income
OperatingIncomeLoss
quarter 2024-06-30$19.6M
10-Q 2024-08-14
$15.6M
10-Q 2025-08-08
-20.6%first · latest
Total assets
Assets
balance at 2021-06-30$623M
10-Q 2021-08-09
$749M
10-Q 2022-08-08
+20.3%first · latest
Operating income
OperatingIncomeLoss
quarter 2024-09-30$14.7M
10-Q 2024-11-08
$12.8M
10-Q 2025-11-07
-12.9%first · latest
Total assets
Assets
balance at 2020-03-31$643M
10-Q 2020-05-21
$594M
10-Q 2021-05-10
-7.6%first · latest
Operating income
OperatingIncomeLoss
quarter 2024-03-31$14.3M
10-Q 2024-05-08
$14.9M
10-Q 2025-05-09
+4.3%first · latest
Operating income
OperatingIncomeLoss
fiscal year 2023-12-31$52.1M
10-K 2024-02-29
$50.5M
10-K 2026-02-27
-3.0%first · latest · 3 filings carry it
Total assets
Assets
balance at 2023-09-30$1.01B
10-Q 2023-11-08
$997M
10-Q 2024-11-08
-1.3%first · latest

First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.

Notes by disclosure type

debt, leases, revenue, segments, contingencies, taxes and more · the filer's own words
Latest annual report10-K FY2025 · filed 20260227View filing
Business combinations · 22,719 characters as filed

4. Acquisitions of Businesses The Companys strategy is to continue acquiring and managing multi-clinic outpatient physical therapy practices, to develop outpatient physical therapy clinics as satellites in existing partnerships and to continue acquiring companies that provide and serve the IIP sector. The consideration paid for each acquisition is derived through arms length negotiations and funded through working capital, borrowings under the Companys revolving credit facilities or proceeds from the secondary offering discussed in Note 1. The finalized purchase prices plus the fair value of the non-controlling interests for the acquisitions in 2024 and 2023 were allocated to the fair value of the assets acquired, inclusive of identifiable intangible assets, i.e. trade names, referral relationships and non-compete agreements, and liabilities assumed based on the fair values at the acquisition date, with the amount exceeding the fair values being recorded as goodwill. For the acquisitions in 2025, the Company is in the process of completing its formal valuation analysis to identify and determine the fair value of tangible and identifiable intangible assets acquired and the liabilities assumed. Thus, the final allocation of the purchase price may differ from the preliminary estimates used at December 31, 2025 based on additional information obtained and completion of the valuation of the identifiable intangible assets. Changes in the estimated valuation of the tangible assets a

BusinessCombinationDisclosureTextBlock · excerpt; the full note is in the filing

Commitments and contingencies · 227 characters as filed

20. Contingencies The Company is a party to various legal actions, proceedings, and claims (some of which are not insured), and regulatory and other governmental audits and investigations in the ordinary course of our business.

CommitmentsAndContingenciesDisclosureTextBlock

Employee benefit plans · 560 characters as filed

19. Defined Contribution Plan The Company has several 401(k) profit sharing plans covering certain employees with three months of service. For certain plans, the Company makes matching contributions. The Company may also make discretionary contributions of up to 50% of employee contributions. The Company did not make any discretionary contributions for the years ended December 31, 2025, 2024 and 2023. The Company matching contributions totaled $3.7 million, $2.6 million and $2.2 million, respectively, for the years ended December 31, 2025, 2024 and 2023.

CompensationAndEmployeeBenefitPlansTextBlock

Debt · 6,685 characters as filed

11. Borrowings Amounts outstanding under the Credit Agreement (as defined below) and notes payable consisted of the following. As of the Year Ended December 31, 2025 December 31, 2024 Principal Amount Unamortized Debt Issuance Cost (2) Net Debt Principal Amount Unamortized Debt Issuance Cost (2) Net Debt (In thousands) Term Facility $ 131,250 $ (620 ) $ 130,630 $ 140,625 $ (1,049 ) $ 139,576 Revolving Facility 30,500 - 30,500 11,000 - $ 11,000 Other (1) 1,329 - 1,329 2,953 - $ 2,953 Total debt 163,079 (620 ) 162,459 154,578 (1,049 ) 153,529 Less: Current portion of long-term debt 10,287 (422 ) 9,865 11,422 (423 ) 10,999 Long-term debt, net of current portion $ 152,792 $ (198 ) $ 152,594 $ 143,156 $ (626 ) $ 142,530 (1) The long-term portion is included as part of Other Long-Term Liabilities in the Consolidated Balance Sheet. (2) Debt issuance costs are amortized over the term of the Term Loan and recorded to interest expense. Effective December 5, 2013, the Company entered into an Amended and Restated Credit Agreement with a commitment for a $125.0 million revolving credit facility. This agreement was amended and/or restated in August 2015, January 2016, March 2017, November 2017, and January 2021. On June 17, 2022, the Company entered into the Third Amended and Restated Credit Agreement (the Credit Agreement) among Bank of America, N.A., as administrative agent (Administrative Agent) and the lenders from time-to-time party thereto. The Credit Agreement, which matures on June

DebtDisclosureTextBlock · excerpt; the full note is in the filing

Share-based compensation · 4,225 characters as filed

17. Equity Based Plans U.S. Physical Therapy Stock Incentive Plans Amended and Restated 1999 Employee Stock Option Plan The Amended and Restated 1999 Employee Stock Option Plan (the Amended 1999 Plan) permits the Company to grant to non-employee directors and employees of the Company up to 600,000 non-qualified options to purchase shares of common stock and restricted stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The exercise prices of options granted under the Amended 1999 Plan are determined by the Compensation Committee. The period within which each option will be exercisable is determined by the Compensation Committee. Amended and Restated 2003 Stock Option Plan The Amended and Restated 2003 Stock Option Plan (the Amended 2003 Plan) permits the Company to grant to key employees and outside directors of the Company incentive and non-qualified options and shares of restricted stock covering up to 2,600,000 shares of common stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). As of December 31, 2025, there were 0.3 million shares remaining that can be subject to new awards under the Amended 2003 Plan. Stock-based compensation expense related to the Amended 1999 Plan and Amended 2003 Plan was approximately $8.3 million, $7.8 million, and $7.7 million for the years ended December 31, 2025, 2024 and 2023 respectively. As of December 31

DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock · excerpt; the full note is in the filing

Income taxes · 5,082 characters as filed

14. Income Taxes Significant components of deferred tax assets and liabilities included in the consolidated balance sheets as of the periods below were as follows. As of the Year Ended December 31, 2025 December 31, 2024 (In thousands) Deferred tax assets: Compensation $ 2,045 $ 2,370 Provision for credit losses 792 747 Lease obligations - including closed clinics 29,888 36,205 Other 94 - Deferred tax assets $ 32,819 $ 39,322 Deferred tax liabilities: Depreciation and amortization $ (31,274 ) $ (32,392 ) Operating lease right-of-use assets (28,109 ) (34,221 ) Gain on cash flow hedge (244 ) (960 ) Change in revaluation of put-right liability (312 ) (638 ) Other (1,271 ) (576 ) Deferred tax liabilities (61,210 ) (68,787 ) Net deferred tax liabilities $ (28,391 ) $ (29,465 ) The deferred tax assets and liabilities related to purchased interests not yet finalized may result in an immaterial adjustment. As of December 31, 2025, the Company has a federal tax payable of $0.9 million and state tax receivables of $3.1 million. The federal tax payable is included in accrued expenses and the state income tax receivable is included in other current assets on the accompanying consolidated balance sheets. For the years ended December 31, 2025, 2024, and 2023 income taxes for financial reporting purposes differ from the amount computed by applying the statutory federal income tax rate of 21% as shown as in the following table: Year Ended December 31, 2025 U.S. federal statutory rate $ 12,47

IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing

Leases · 3,482 characters as filed

13. Leases The Company has operating leases for its corporate offices and operating facilities. The Company determines if an arrangement is a lease at the inception of a contract. Right-of-use assets represent the Companys right to use an underlying asset during the lease term and operating lease liabilities represent net present value of the Companys obligation to make lease payments arising from the lease. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the net present value of the fixed lease payments over the lease term. The Companys operating lease terms are generally five years or less. The Companys lease terms include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. As most of the Companys operating leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Operating fixed lease expense is recognized on a straight-line basis over the lease term. Variable lease payment amounts that cannot be determined at the commencement of the lease such as increases in lease payments based on changes in index rates or usage are not included in the right-of-use assets or operating lease liabilities. These are expensed as incurred and recorded as variable lease expense. The components of lease expense were as follows. For the Year Ended December 3

LesseeOperatingLeasesTextBlock · excerpt; the full note is in the filing

New accounting pronouncements · 2,887 characters as filed

Recently Adopted Accounting Guidance On July 4, 2025, the President signed H.R. 1, the One Big Beautiful Bill Act, into law. The legislation did not have a material impact on the Companys income tax expense for the year ended December 31, 2025, nor did it materially change the Companys effective income tax rate for 2025. On December 14, 2023, the FASB issued ASU 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disclosure on an annual basis, a tabular reconciliation, including both amount and percentage of specific categories of the effective tax rate reconciliation, including state and local income taxes (net of Federal taxes), foreign taxes, effects of changes in tax laws and regulations, effects of cross-border tax laws, tax credits, changes in valuation allowances, nontaxable and nondeductible items and changes in unrecognized tax benefits. Additional disclosures are required for certain items exceeding five percent of income from continuing operations multiplied by the statutory income tax rate. The standard also requires disclosure of income taxes paid between Federal, state and foreign jurisdictions, including further disaggregation of those payments exceeding five percent of the total income taxes paid. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, and early adoption is permitted. The Company adopted this standard as of January 1, 2025, utilizing the prospective application as permitted in the stand

NewAccountingPronouncementsPolicyPolicyTextBlock · excerpt; the full note is in the filing

Segment reporting · 7,078 characters as filed

15. Segment Information The Companys reportable segments include the physical therapy operations segment and the IIP segment. Also included in the physical therapy operations segment are revenues from management contract services and other services which include services the Company provides on-site, such as athletic trainers for schools . Physical Therapy Operations The physical therapy operations segment primarily operates through subsidiary clinic partnerships (Clinic Partnerships), in which the Company generally owns a 1% general partnership interest in all the Clinic Partnerships. The Companys limited partnership interests generally range from 65% to 75% (the range is 30% - 99%) in the Clinic Partnerships. The managing therapist of each clinic owns, directly or indirectly, the remaining limited partnership interest in most of the clinics (hereinafter referred to as Clinic Partnerships). Some of the Clinic Partnerships serve as management services organizations which manage and provide staffing and a variety of administrative services to physical therapy provider entities in which the Company does not have an ownership interest. These Clinic Partnerships similarly are owned collectively by the Company and one or more physical therapists who are involved in the management of the operations. To a lesser extent, the Company operates some clinics through wholly-owned subsidiaries (hereinafter referred to as Wholly-Owned Facilities). The Company continues to seek to attract fo

SegmentReportingDisclosureTextBlock · excerpt; the full note is in the filing

Significant accounting policies · 33,820 characters as filed

2. Significant Accounting Policies Cash Equivalents The Company maintains its cash and cash equivalents at financial institutions. The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (FDIC) insurance coverage and, as a result, there is a concentration of credit risk related to amounts on deposit in excess of FDIC insurance coverage. Management believes that this risk is not significant. Long-Lived Assets Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the related assets. Estimated useful lives for furniture and equipment range from three to eight years and for software purchased from three to seven years. Leasehold improvements are amortized over the shorter of the related lease term or estimated useful lives of the assets, which is generally three to five years. Goodwill and Other Indefinite-Lived Intangible Assets Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009 , from the purchase of some or all of a particular local managements equity interest in an existing clinic. Effective January 1,

SignificantAccountingPoliciesTextBlock · excerpt; the full note is in the filing

Stockholders' equity · 3,847 characters as filed

18. Preferred and Common Stock Preferred Stock The Board is empowered, without approval of the shareholders, to cause shares of preferred stock to be issued in one or more series and to establish the number of shares to be included in each such series and rights, powers, preferences, and limitations of each series. There are no provisions in the Companys Articles of Incorporation specifying the vote required by the holders of preferred stock to take action. All such provisions would be set out in the designation of any series of preferred stock established by the Board. The bylaws of the Company specify that, when a quorum is present at any meeting, the vote of the holders of at least a majority of the outstanding shares entitled to vote who are present, in person or by proxy, shall decide any question brought before the meeting, unless a different vote is required by law of the Companys Articles of Incorporation. Because the Board has the power to establish the preferences and rights of each series, it may afford the holders of any series of preferred stock, preferences, powers, and rights, voting or otherwise, senior to the right of holders of common stock. The issuance of the preferred stock could have the effect of delaying or preventing a change in control of the Company. Common Stock In May 2023, the Company completed a secondary offering of 1,916,667 shares of its common stock at an offering price of $90.00 per share. Upon completion of the offering, the Company receiv

StockholdersEquityNoteDisclosureTextBlock · excerpt; the full note is in the filing

Subsequent events · 1,398 characters as filed

21. Subsequent Events On January 2, 2026, the Company acquired an eight-clinic practice with eight clinic locations. The prior owners retained 50% ownership interest. On January 31, 2026, the Company acquired 70% of an industrial injury prevention business. The previous owners retained a 30% ownership interest. On February 2, 2026, we announced a 10-year strategic alliance between our subsidiary partner, Metro, and a prominent New York hospital system, whereby 60 of Metros existing outpatient physical therapy clinics in New York will become part of the hospital systems clinical services network. The alliance is expected to begin operations with an initial group of clinics in mid-2026, with all 60 clinics anticipated to be operational by year-end 2026. On February 24, 2026, the Companys Board of Directors raised the Companys quarterly dividend rate from $0.45 per share to $0.46 per share, effective immediately, and declared a quarterly dividend for the first quarter of 2026 at the higher rate. The dividend will be payable on April 10, 2026, to shareholders of record on March 13, 2026. On February 25, 2026, the Company announced a 10-year strategic alliance between another of its subsidiary partners and a local hospital system whereby the subsidiary partners existing 10 outpatient physical therapy clinics will become part of the hospital systems clinical services network.

SubsequentEventsTextBlock · excerpt; the full note is in the filing

Source: SEC DERA Financial Statement and Notes data sets (txt.tsv), excerpts of the filer's own note text; the full note is in the linked filing. Excerpts are the first part of each note exactly as tagged in the filing; open the filing for the full text and the tables. Descriptive and educational, not advice.

Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.

Educational content only. Not financial advice. TrendNalysis provides educational and informational financial analysis built from public SEC filings and economic data (FRED, BLS). It is not financial, investment, tax, or legal advice and is not a recommendation to buy or sell any security. Market pricing is not currently included. Past performance does not guarantee future results. Always do your own research and consult a licensed financial professional before investing.